Kwality Pharmaceuticals Q2 Results Live : Kwality Pharmaceuticals declared their Q2 results on 30 Oct, 2024, showcasing a remarkable performance with the topline increasing by 29.27% year-over-year, while profit surged by 35.83% compared to the same quarter last year.
In comparison to the previous quarter, the company reported a revenue growth of 12.43% and a profit increase of 1.36%, indicating consistent upward momentum.
However, the company faced rising Selling, General & Administrative expenses, which climbed by 5.96% quarter-over-quarter and saw a significant increase of 30.04% year-over-year, reflecting higher operational costs.
Despite the increase in expenses, Kwality Pharmaceuticals reported a robust operating income growth of 12.91% quarter-over-quarter and an impressive 45.35% year-over-year, signaling strong operational efficiency.
The Earnings Per Share (EPS) for Q2 stood at ₹8.15, marking a 36.06% increase year-over-year, further highlighting the company’s profitability growth.
In terms of market performance, Kwality Pharmaceuticals has delivered an impressive 18.93% return in the last week, a staggering 86.7% in the last six months, and an astonishing 133.09% return year-to-date.
Currently, Kwality Pharmaceuticals has a market capitalization of ₹966.96 Crores, with its stock trading between a 52-week high of ₹944.8 and a low of ₹320, reflecting significant investor confidence.
Kwality Pharmaceuticals Financials
| Period | Q2 | Q1 | Q-o-Q Growth | Q2 | Y-o-Y Growth |
|---|---|---|---|---|---|
| Total Revenue | 90.03 | 80.08 | +12.43% | 69.65 | +29.27% |
| Selling/ General/ Admin Expenses Total | 10.31 | 9.73 | +5.96% | 7.92 | +30.04% |
| Depreciation/ Amortization | 4.62 | 4.03 | +14.84% | 4.88 | -5.37% |
| Total Operating Expense | 75 | 66.76 | +12.34% | 59.3 | +26.46% |
| Operating Income | 15.04 | 13.32 | +12.91% | 10.35 | +45.35% |
| Net Income Before Taxes | 12.55 | 11.12 | +12.91% | 8.17 | +53.69% |
| Net Income | 8.47 | 8.36 | +1.36% | 6.24 | +35.83% |
| Diluted Normalized EPS | 8.15 | 8.04 | +1.37% | 5.99 | +36.06% |
